| Literature DB >> 28841278 |
Shane M Wilkinson, Melissa L Barron, James O'Brien-Brown, Bieneke Janssen1, Leanne Stokes2, Eryn L Werry, Mansoor Chishty3, Kristen K Skarratt, Jennifer A Ong, David E Hibbs, Danielle J Vugts1, Stephen Fuller, Albert D Windhorst1, Michael Kassiou.
Abstract
Adamantanyl benzamide 1 was identified as a potent P2X7R antagonist but failed to progress further due to poor metabolic stability. We describe the synthesis and SAR of a series of bioisosteres of benzamide 1 to explore improvements in the pharmacological properties of this lead. Initial efforts investigated a series of heteroaromatic bioisosteres, which demonstrated improved physicochemical properties but reduced P2X7R antagonism. Installation of bioisosteric fluorine on the adamantane bridgeheads was well tolerated and led to a series of bioisosteres with improved physicochemical properties and metabolic stability. Trifluorinated benzamide 34 demonstrated optimal physicochemical parameters, superior metabolic stability (ten times longer than lead benzamide 1), and an improved physicokinetic profile and proved effective in the presence of several known P2X7R polymorphisms.Entities:
Keywords: P2X7; bioisostere; central nervous system (CNS); metabolism; pharmacokinetic; single nucleotide polymorphisms (SNPs)
Mesh：
Substances：
Year: 2017 PMID： 28841278 DOI： 10.1021/acschemneuro.7b00272
Source DB: PubMed Journal: ACS Chem Neurosci ISSN： 1948-7193 Impact factor: 4.418